Real-world first-line serplulimab-based immunochemotherapy for extensive-stage small cell lung cancer: The multicenter ASTRUM-005R study.

被引：0
|
作者：
Wu, Lin
Hu, ChengPing
Su, Wenzhong
Yu, Yan
Hong, Wei
Liu, Zhigang
Su, Haichuan
Liu, Zhentian
Wang, Caixia
Pu, Qing
Guo, Hui, Sr.
Min, Xuhong
Chen, Yifei
机构：
[1] Cent South Univ, Hunan Canc Hosp, Affiliated Canc Hosp, Dept Thorac Med Oncol,Xiangya Sch Med, Changsha, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Dept Resp & Crit Care Med, Changsha, Hunan, Peoples R China
[3] Shanxi Med Univ, Shanxi Canc Hosp, Canc Hosp, Shanxi Canc Inst,Affiliated Hosp,Shanxi Hosp,Chin, Taiyuan, Peoples R China
[4] Harbin Med Univ, Canc Hosp, Harbin, Peoples R China
[5] Univ Chinese Acad Sci, Canc Hosp, Dept Chest Oncol, Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
[6] Southern Med Univ, Affiliated Hosp 10, Ctr Canc, Dongguan Peoples Hosp, Dongguan, Peoples R China
[7] Air Force Med Univ, Dept Oncol Tangdu Hosp, Xian, Shaanxi, Peoples R China
[8] Jiangxi Canc Hosp, Dept Chest Oncol, Nanchang, Jiangxi, Peoples R China
[9] Shandong First Med Univ, Chemotherapy Dept, Oncol Ctr, Shandong Prov Hosp, Jinan, Peoples R China
[10] Guangxi Med Univ, Dept Oncol, Affiliated Hosp 1, Nanning, Peoples R China
[11] Xi An Jiao Tong Univ, Affiliated Hosp 2, Xian, Peoples R China
[12] Anhui Chest Hosp, Oncol Radiotherapy Dept, Hefei, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20106
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A Real-World Study of the Efficacy of Immune-Checkpoint Inhibitors for Extensive-Stage Small Cell Lung Cancer
    Liu, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E411 - E411
  • [32] Extensive-Stage Small-Cell Lung Cancer: First-Line and Second-Line Treatment Options
    Zugazagoitia, Jon
    Paz-Ares, Luis
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06) : 671 - +
  • [33] Real-world evidence of cancer immunotherapy (CIT) combination treatment in first-line (1L) extensive-stage small cell lung cancer (ES-SCLC).
    Nadler, Eric S.
    Vasudevan, Anupama
    Davies, Kalatu
    Wang, Yunfei
    Johnson, Ann
    Ogale, Sarika
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [34] A real-world multicentre evaluation of atezolizumab plus platinum-etoposide chemotherapy as first-line treatment in patients with extensive-stage small cell lung cancer in Italy
    Musicco, Felice
    Fulgenzio, Chiara
    La Malfa, Antonia
    Jannitti, Nicoletta
    Vitiello, Antonietta
    Carpano, Silvia
    Fusco, Francesca
    Cappuzzo, Federico
    Terrenato, Irene
    Sperduti, Isabella
    Polidori, Piera
    Tarantino, Domenico
    Di Cerbo, Lidia
    Pani, Marcello
    Isgro, Valentina
    Lasala, Ruggero
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024,
  • [35] Real-World Outcomes of Platinum-immunotherapy as First-Line (1L) Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
    Ganti, A. K.
    Prince, T.
    Back, S.
    Chansakul, A.
    Boccuti, A.
    Rengarajan, B.
    Chakrabarti, D.
    Li, W.
    Fan, L.
    Cao, Y.
    D'Agostino, R., Jr.
    Fan, X.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S664 - S665
  • [36] Recent treatment patterns and real-world survival following first-line anti-PD-L1 treatment for extensive-stage small cell lung cancer
    Shaw, Jaime
    Pundole, Xerxes
    Balasubramanian, Akhila
    Anderson, Erik S.
    Pastel, Malaika
    Bebb, D. Gwyn
    Jiang, Tony
    Martinez, Pablo
    Ramalingam, Suresh S.
    Borghaei, Hossein
    ONCOLOGIST, 2024, 29 (12): : 1079 - 1089
  • [37] Real-world evaluation of first-line treatment of extensive-stage small-cell lung cancer with atezolizumab plus platinum/etoposide: a focus on patients with brain metastasis
    Chen, Hanxiao
    Ma, Xiangjuan
    Liu, Jie
    Yang, Yu
    He, Yanhui
    Fang, Yong
    Wang, Liping
    Fang, Jian
    Zhao, Jun
    Zhuo, Minglei
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (07): : 1664 - 1673
  • [38] Association Between Sarcopenia, Clinical Outcomes, and Survival in Patients with Extensive-Stage Small Cell Lung Cancer Treated with First-Line Immunochemotherapy: A Prospective Cohort Study
    Tian, Le
    Huang, Jia-Xin
    Wan, Rui
    Zhang, Jie
    Zhang, Xi
    Li, Ning
    Li, Na
    Liu, Xin-Qi
    Song, Chen-Xin
    Wang, Xin-Yi
    Yu, Lei
    Wang, Shao-Ming
    Wang, Zhi-Jie
    Cong, Ming-Hua
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2025, 77 (01): : 62 - 69
  • [39] First-line apatinib plus chemotherapy in extensive-stage small-cell lung cancer.
    Shi, Jian
    Liu, Jiayin
    Duan, Xiaoyang
    Huang, Guanglei
    Wang, Lixing
    Zhao, Yan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [40] Economic Evaluation of First-Line Atezolizumab for Extensive-Stage Small-Cell Lung Cancer in the US
    Wang, Yingcheng
    Rui, Mingjun
    Yang, Lan
    Wang, Xintian
    Shang, Ye
    Ma, Aixia
    Li, Hongchao
    FRONTIERS IN PUBLIC HEALTH, 2021, 9
12345